The Safety of Available Immunotherapy for the Treatment of Glioblastoma

INTRODUCTION: Glioblastoma (GBM) is the most common malignant primary brain tumor in adults. Current standard of care involves maximal surgical resection combined with adjuvant chemoradiation. Growing support exists for a role of immunotherapy in treating these tumors with the goal of targeted cytot...

Full description

Saved in:
Bibliographic Details
Published in:Expert Opin Drug Saf
Main Authors: Farber, S. Harrison, Elsamadicy, Aladine A., Atik, Fatih, Suryadevara, Carter M., Chongsathidkiet, Pakawat, Fecci, Peter E., Sampson, John H.
Format: Artigo
Language:Inglês
Published: 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5404815/
https://ncbi.nlm.nih.gov/pubmed/27989218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14740338.2017.1273898
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items